GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B7261 Desipramine hydrochlorideSummary: noradrenalin transporters inhibitor
- B7278 UDP disodium saltSummary: Endogenous P2Y receptor agonist
- B7283 2-ChloroadenosineSummary: adenosine receptor agonist
- B7284 BAY-u 9773Summary: Antagonist of CysLT1/CysLT2 receptors
- B7340 2-ThioUTP tetrasodium saltSummary: P2Y2 agonist
- B7345 Oxprenolol hydrochlorideSummary: β-adrenergic inhibitor
- B7348 SN 003Summary: CRF1 antagonist
- B7403 M40Summary: galanin receptor antagonist
- B7408 [D-Trp34]-Neuropeptide YSummary: neuropeptide Y (NPY) Y5 receptor agonist
- B7411 Cyclosomatostatin1 CitationSummary: somatostatin receptor antagonist